Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity
Open Access
- 20 October 2020
- journal article
- research article
- Published by Springer Nature in JA Clinical Reports
- Vol. 6 (1) , 1-5
Abstract
Background: An increasing number of patients come to the operating room in use of opioid analgesics. They have different levels of tolerance to opioid effects which challenge the anesthesiologists in search of safe and effective opioid dosing perioperatively. The tested hypothesis is that simple measures introduced will allow us to measure tolerance qualitatively. Opioid effects on pain (analgesia) and dyspnea sensations (relieving effect) are tested. Patients were allocated to three groups according to pre-operative analgesics: (1) control, without any opioid analgesics, (2) weak opioid, and (3) strong opioid. Pressure pain threshold (PPT) and no-respiratory sensation period (NRSP) were measured at two points: before and 3 min after intravenous fentanyl administration. Results: A total of 58 (43 controls, 9 weak opioids, and 6 strong opioids) patients were enrolled. PPT and NRSP, after iv 2 μg/kg ideal body weight (IBW) fentanyl, were significantly elevated in the control patients (PPT: 6.2 ± 2.1 N to 9.2 ± 3.9 N, p < 0.0001, NRSP: 17.8 ± 10.8 s to 22.8 ± 18.7 s, p < 0.005, paired t test). However, preoperative opioid use, though with tendency, did not show a significant decrease of the opioid effect. Due to an insufficient number of participants, no conclusion could be drawn. Further analysis of the data from control patients showed a significant difference between the two sexes in sensitivity to PPT and NRSP, as well as fentanyl effect on PPT. Conclusions: Current data showed a simple method of measuring the opioid effect on two dimensions: pain and respiration. Though not able to show a qualitative measurement of tolerance formation in opioid-users, data from control patients showed females to be more sensitive to pain and dyspnea but is less sensitive to the opioid effect. Further studies are necessary to show whether these gender differences serve as clinical relevance. Trial registration: UMIN, UMIN 000011580. Registered 27 August 2013, https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000013352&language=JKeywords
This publication has 10 references indexed in Scilit:
- Efficacy and Safety of Opioids in Treating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis Based on Randomized Controlled TrialsJournal of Pain and Symptom Management, 2021
- A New Real-time Method for Detecting the Effect of Fentanyl Using the Preoperative Pressure Pain Threshold and Narcotrend IndexMedicine, 2015
- Sex differences in pain: a brief review of clinical and experimental findingsBritish Journal of Anaesthesia, 2013
- Using Laboratory Models to Test Treatment: Morphine Reduces Dyspnea and Hypercapnic Ventilatory ResponseAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Comparison of pain and dyspnea perceptual responses in healthy subjectsPain, 2010
- Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic PerspectiveThe AAPS Journal, 2008
- Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphinePain, 2006
- Morphine responses and experimental pain: Sex differences in side effects and cardiovascular responses but not analgesiaThe Journal of Pain, 2005
- Sex-related Differences in the Influence of Morphine on Ventilatory Control in HumansAnesthesiology, 1998
- Changes in the Period of No Respiratory Sensation and Total Breath-Holding Time in Successive Breath-Holding TrialsClinical Science, 1996